Auxin takes root

November 30, 2000

As published in the December 1st issue of Genes & Development, Dr. Nam-Hai Chua and his team at Rockefeller University in New York have begun to unravel the molecular mechanisms by which plants develop roots. Roots are formed during embryonic development, and provide stability and a means of nutrient absorbtion during the life of the plant. The plant hormone, auxin, has been linked to root formation, but the actual pathway of its action has, until recently, remained a mystery.

Dr. Chua and colleagues began their investigation of the auxin signaling pathway with a novel plant gene called NAC1. NAC1 shows no similarity to any known gene in animals or yeast, so its function was totally unknown. To gain insight into the function of NAC1, Dr. Chua and colleagues investigated the expression and activity patterns of the NAC1 protein. The scientists found that NAC1 is expressed in the root tips, and that switching the gene on or off increased or reduced the number of emerging roots, respectively. Furthermore, they found that NAC1 functions in the nucleus by binding to DNA. Using these insights, the team was able to identify NAC1 as a classical gene regulator. Dr. Chua and colleagues then went on to discover two targets of NAC1, both of which had already been shown to be responsive to auxin signaling. However, a question still remained as to what regulates NAC1.

Finally, NAC1 was linked to the auxin pathway by demonstrating that NAC1 is regulated by auxin, and that the effect of auxin on root formation is mediated by NAC1. NAC1 can even compensate for the lack of another gene, tir1, which has previously been established as a mediator of auxin signaling. This is the first study to define a role for Nac1 in root development. The strides which Dr. Chua and his colleagues have made in delineating the pathway of auxin signaling represents a tremendous advance in the understanding of the molecular pathway of root development.
-end-


Cold Spring Harbor Laboratory

Related Gene Articles from Brightsurf:

NIH gene therapy startup to increase AAV gene therapy efficiency
Maximizing the efficiency of the adeno-associated virus (AAV) platform for gene therapy is the aim of a new pilot project of the National Institutes of Health (NIH).

Alzheimer's risk gene disrupts endocytosis, but another disease-linked gene could help
MIT researchers find that astrocytes with the risk-increasing APOE4 variant show deficits of key cellular function called endocytosis, but overexpressing another Alzheimer's associated gene, PICALM, overcame the defect

New Human Gene Therapy editorial: Concern following gene therapy adverse events
Response to the recent report of the deaths of two children receiving high doses of a gene therapy vector (AAV8) in a Phase I trial for X-linked myotubular myopathy (MTM).

Gene therapy/gene editing combo could offer hope for some genetic disorders
A hybrid approach that combines elements of gene therapy with gene editing converted an experimental model of a rare genetic disease into a milder form, significantly enhancing survival, shows a multi-institutional study led by the University of Pennsylvania and Children's National Hospital in Washington, D.C.

Unraveling gene expression
EPFL chemists have uncovered the first steps in the process of gene expression by showing how the protein Rap1 pries open the tightly wound, compacted structure of DNA in the cell to gain access to specific genes.

Gene coding error found in rare, inherited gene cof lung-scarring disorder linked to short telomeres
By combing through the entire genetic sequences of a person with a lung scarring disease and 13 of the person's relatives, Johns Hopkins Medicine researchers say they have found a coding error in a single gene that is likely responsible for a rare form of the disease and the abnormally short protective DNA caps on chromosomes long associated with it.

The two faces of the Jekyll gene
Genes which are specific to a species or group of species can reflect important genetic changes within lineages.

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.

Blindness gene discovered
Researchers from UNIGE have investigated a recessive genetic disorder that destroys the eyes from developing and results in childhood blindness.

Gene editing just got easier
An international team of researchers has made CRISPR technology more accessible and standardized by simplifying its complex implementation in a way that offers a broad platform for off-the shelf genome engineering.

Read More: Gene News and Gene Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.